Corcept Therapeutics revenue
Corcept Therapeutics (CORT) reported revenue of $761.41 M for fiscal year 2025, +12.8% compared with the year before. Over the last 12 months revenue was $963.65 M.
Revenue 2025$761.41 M
Change+12.8%
World rank#1125
Market cap$7.42 B
Revenue by year
By year
| Year | Value | Change |
|---|---|---|
| 2025 | $761.41 M | +12.8% |
| 2024 | $675.04 M | +39.9% |
| 2023 | $482.38 M | +20.0% |
| 2022 | $401.86 M | — |
Data: company filings via Yahoo Finance, updated 2026-11-19. Not investment advice.